CVS and Gilead Sciences strike an exclusive deal for hepatitis drugs Sovaldi and Harvoni. The total cost of treatment via Sovaldi can reach up to $84,000 for 12 weeks.
CVS and Gilead Sciences strike an exclusive deal for hepatitis drugs Sovaldi and Harvoni. The total cost of treatment via Sovaldi can reach up to $84,000 for 12 weeks.
Share this Article
Recommended